Is a complete STRO research report available?

No complete published report is available for Sutro Biopharma, Inc. (STRO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Sutro Biopharma, Inc. (STRO)

NASDAQ: STRO · USD

$22.9

-0.72 (-3.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first STRO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	379.1M
Revenue (ttm)	99.6M
Net income (ttm)	-153.6M
EPS (ttm)	-$15.9
Shares out	16.6M
Volume	327,979
Beta	1.52
Price target	$47.8	+108.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 99.6M
Net income (ttm): -153.6M
EPS (ttm): -$15.9
Market cap: 379.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All STRO indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001382101
Company name	Sutro Biopharma, Inc.
Country	United States
Country code	US
Cusip	869367201
Employees	133
Employees Change	-4%
Employees Change Percent	-2.92
Enterprise value	$190.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-09-27
Isin	US8693672011
Last refreshed	2026-07-27
Market cap	$379.1M
Market cap category	Small-Cap
Price	$22.88
Price currency	USD
Rev Per Employee	748,932.33x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2836
Symbol	STRO
Website	https://www.sutrobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.51%
EV Sales Forward	5.26x
EV/Sales	1.91x
FCF yield	-40.13%
P/S ratio	3.81x
PS Forward	10.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-119.98%
EBITDA Margin	-113.25%
Gross margin	-51.97%
Gross Profit	$-51.8M
Net Income	$-153.6M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-154.32%
Profit Margin	-154.21%
Profit Per Employee	$-1.2M
ROA	-19.32
Roa5y	-21.82
ROCE	-69.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	164.87%
Cagr3y	-21.72%
Cagr5y	-33.09%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	49.94x
Revenue Growth Q	-16.53x
Revenue Growth Years	1x
Revenue Growth3 Y	10.14x
Revenue Growth5 Y	14.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.35
Assets	$242M
Cash	$202.6M
Current Assets	$221M
Current Liabilities	$70.8M
Debt	$13.6M
Equity	$-66.9M
Interest Coverage	-2.85
Liabilities	$308.9M
Long Term Assets	$21M
Long Term Liabilities	$238.1M
Net Cash	$188.9M
Net Cash By Market Cap	$49.83
Net Cash Growth	-16.98%
Tangible Book Value	$-66.9M
Tangible Book Value Per Share	$-4.04
WACC	20.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.12
Net Working Capital	$-44.8M
Quick ratio	3.04
Working Capital	$150.2M
Working Capital Turnover	$0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.72%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	164.69%
200-day SMA	20.32
3Y total return	-52.03%
50-day SMA	28.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-86.59%
All Time High	283
All Time High Change	-91.92%
All Time High Date	2021-02-08
All Time Low	5.23
All Time Low Change	337.39%
All Time Low Date	2025-04-17
ATR	2.27
Beta	1.52
Beta1y	2.41
Beta2y	3.56
Ch YTD	97.75
High	23.72
High52	43.85
High52 Date	2026-05-15
High52ch	-47.82%
Low	21.72
Low52	7.15
Low52 Date	2025-12-03
Low52ch	220%
Ma50ch	-20.83%
Price vs 200-day SMA	12.58%
RSI	34.03
RSI Monthly	47.65
RSI Weekly	47.86
Sharpe ratio	1.48x
Sortino ratio	2.45
Total Return	-16.72%
Tr YTD	97.75
Tr1m	-21.62%
Tr1w	-2.93%
Tr3m	-34.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	8
Analyst Price Target Top	$47.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-2.33
Earnings Revenue Estimate	10,697,464x
Earnings Revenue Estimate Growth	-83.22x
Operating Income	$-87.1M
Operating margin	-87.44
Price target	$47.75
Price Target Change	$109
Price Target Change Top	$107

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,302,201%
Float Percent	62.17%
Shares Insiders	0.96%
Shares Institutions	53.38%
Shares Out	16,570,439
Shares Qo Q	49.79%
Shares Yo Y	16.72%
Short Float	13.22%
Short Ratio	3.33
Short Shares	8.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-162.2M
Average Volume	475,256.7x
Bv Per Share	-4.04
CAPEX	$-532,000
Ch1m	-21.62
Ch1w	-2.93
Ch1y	164.7
Ch3m	-34.31
Ch3y	-52.03
Ch5y	-86.59
Ch6m	52.03
Change	-3.05%
Change From Open	-2.97
Close	23.6
Days Gap	-0.08
Depreciation Amortization	6,702,000
Dollar Volume	7,504,159.5
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-119.5M
EBITDA	$-112.8M
EPS	$-15.87
F Score	4
FCF	$-152.1M
FCF EV Yield	-79.99x
FCF Per Share	$-9.18
Financing CF	103,053,000
Fiscal Year End	December
Founded	2,003
Income Tax	$-115,000
Investing CF	16,007,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2025-12-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-23
Ma150	23.99
Ma150ch	-4.63%
Ma20	27.74
Ma20ch	-17.5%
Net CF	-32,547,000
Next Earnings Date	2026-08-06
Open	23.58
Optionable	Yes
Position In Range	58
Post Close	22.88
Postmarket Change Percent	0.04
Postmarket Price	$22.89
Ppne	19,070,000
Price Date	2026-07-24
Relative Volume	0.69x
Revenue	99,608,000x
SBC By Revenue	10.07x
Share Based Comp	10,032,000
Tax By Revenue	-0.12x
Tr6m	52.03%
Us State	California
Volume	327,979
Z Score	-5.69

Sutro Biopharma, Inc. (STRO)

Coverage state: Market snapshot only — no published research

Generate the first STRO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · STRO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STRO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on STRO

Frequently asked questions